Texas Instruments Suffers Worst Rout Since ’08 on Tepid Forecast

Texas Instruments (TI) shares suffered their steepest decline in 17 years, falling up to 13%, as investors grew concerned that recent sales growth was inflated by tariff-driven "pull-in" orders. Despite a Q3 revenue forecast that largely met expectations, the company's guarded outlook and executives' inability to quantify the tariff impact fueled fears of a significant sales deceleration, with Q3 growth projected to slow to 11% from 16% in the prior quarter.

Analysis

Texas Instruments (TXN) experienced its most severe single-day stock decline in 17 years, falling as much as 13%, despite issuing a third-quarter revenue forecast that largely met analyst expectations. The sell-off was not triggered by the quantitative guidance itself—a revenue range of $4.45 billion to $4.8 billion against a $4.57 billion consensus—but by a significant erosion in investor confidence regarding the quality and sustainability of its sales growth. The core issue is the unquantified impact of tariff-related "pull-in," where customers accelerated purchases to pre-empt levies, artificially inflating the previous quarter's strong 16% revenue jump. Management's admission during the conference call that they "don't really know" the magnitude of this effect, coupled with a perceived pessimistic shift in their tone, created deep uncertainty. This ambiguity overshadowed the otherwise solid forecast and fueled fears that the projected growth deceleration to 11% in the upcoming quarter could be the start of a more pronounced slowdown once the temporary demand normalizes.

Key Decisions for Investors

• Investors should recognize that the stock's sharp 13% decline reflects a significant sentiment shift driven by uncertainty over the sustainability of sales, not a clear miss on quantitative guidance, presenting a potential valuation dislocation for those with a higher risk tolerance.
• It is critical to monitor for evidence of demand normalization in the coming quarters to determine if the recent 16% revenue growth was an anomaly and if the projected deceleration to 11% marks a new, lower baseline for growth.
• Given management's inability to quantify the tariff impact and the perceived negative shift in tone, any position should be weighed against the heightened risk of near-term earnings volatility and potential further guidance revisions.